Loading...
XSHG
600129
Market cap1.11bUSD
Oct 09, Last price  
13.97CNY
1D
4.10%
1Q
-15.74%
Jan 2017
-18.54%
Name

Chongqing Taiji Industry(Group)Co.

Chart & performance

D1W1MN
XSHG:600129 chart
P/E
63.89
P/S
0.74
EPS
0.22
Div yield, %
2.24%
Shrs. gr., 5y
-0.05%
Rev. gr., 5y
-1.39%
Revenues
10.45b
-15.65%
4,078,194,3654,504,415,6824,814,879,5905,275,145,7125,985,619,8246,385,801,3546,602,726,8586,603,077,7146,958,053,4797,171,457,1997,951,835,6478,773,263,62110,689,384,28111,643,087,42611,207,803,71012,149,432,71814,127,402,32915,622,648,41612,386,016,98310,448,111,281
Net income
121m
+352.37%
63,259,15363,591,64423,501,00037,699,879-161,585,70920,679,704-220,449,94812,559,824-276,635,697231,606,902856,210,86397,738,75270,263,499-70,830,33266,067,064-523,174,253354,381,880822,124,92526,652,733120,570,288
CFO
587m
P
273,533,360240,007,181297,456,589338,274,782124,967,518172,379,99880,079,87000000104,409,864327,246,057749,791,289558,812,7951,800,768,932671,536,615-631,462,933587,241,863
Dividend
Jun 07, 20240.3 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Chongqing Taiji Industry (Group) Co.,Ltd operates as a pharmaceutical enterprise, conducting business both within China and across international markets. The company focuses on the research, development, manufacturing, and distribution of traditional Chinese medicines and various health products. Its offerings are available in a wide array of formats, including tablets, oral liquids, syrups, dripping pills, granules, capsules, tinctures, and powders. The product line addresses a comprehensive range of health conditions and therapeutic areas. These include disorders of the digestive and respiratory systems, cardiovascular and cerebrovascular ailments, pediatric and gynecological health, systemic anti-infective agents and antibiotics, pain relief medications, orthopedic treatments, remedies for colds and coughs, and drugs for the endocrine and nervous systems. The firm's headquarters are situated in Chongqing, China.

Key people

Chairman of the Board · since 1993
Wansen Zhou
Chief Accounting Officer · since 2017
Heping Chen
Deputy General Manager · since 2012
Kang Chen
Deputy General Manager · since 2012
Haiyan Cui
Deputy General Manager · since 2012
Weidong Ding
Deputy General Manager · since 2012
Yanxi Dong
Deputy General Manager · since 2013
Lihui Feng
Deputy General Manager · since 2012
Jin Lu
Deputy General Manager · since 2012
Shisui Luo
Deputy General Manager · since 2019
Ronghua Wang
Deputy General Manager · since 2012
Jing Yang
Deputy General Manager · since 2012
Weiming Yu
Deputy General Manager · since 2012
Feiming Zheng
Deputy General Manager · since 2006
Yuwen Qin
Chief Engineer · since 2018
Qian Jiang
Secretary of the Board, Director · since 2015
Er Wei Ai
Director
Zhiping Chen
Director · since 2010
Jianguo Feng
Director · since 2012
Min Hu
Director · since 2012
IPO date
Nov 18, 1997
Employees
Domiciled in
CN
Incorporated in
CN
Headquarters & legal address
重庆市涪陵区太极大道1号
涪陵区, CQ 100000
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT